Method of treating schizophrenia prodrome
US8492418B2 · kind B2 · utility
7Cited by
0References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 11, 2006 |
| Grant date | Jul 23, 2013 |
| Priority date | — |
| Expiry date | May 11, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a method of treating schizophrenia prodrome in human subjects using a NMDA glycine site agonist, a glycine transporter-1 inhibitor or mixtures thereof, optionally in combination with a pharmaceutically acceptable additive, carrier or excipient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.